-
News | 2021.03.04
Pfbioassays
The Institut Pasteur will be setting up the project Pfbioassays (in French) funded by the French government and the Greater Paris Region, on its campus (Thierry Rose and Sébastien Quesney). The aim of the project is to develop a highly automated technological bioassay system involving the packaging and analysis of serum samples. This new system, based on state-of-the-art...
-
News | 2022.06.14
A New Drug Target against Malaria
Malaria is a disease that continues to cause tremendous suffering and mortality in the tropics. This disease is caused by Plasmodium parasites. The species Plasmodium falciparum causes the severest and most deadly form of malaria. Scientists from Institut Pasteur studied the blood stage of the parasites and found a mechanism which could lead to new and efficient drugs against Malaria.Despite...
-
Document de presse | 2022.06.15
COVID-19: Identification of broadly SARS-CoV-2 neutralizing monoclonal antibodies
Although the different SARS-CoV-2 variants currently in circulation are undoubtedly less severe in vaccinated individuals in the general population, immunocompromised people are at greater risk of developing severe forms of COVID-19. Monoclonal antibodies currently offer the best approach, both as a preventive and curative treatment for these patients. Scientists from the Institut Pasteur and...
-
Article | 2022.06.20
4-year Research Group in entomology within Centre Pasteur Cameroun
To reinforce the research on arbovirus transmission at the Centre Pasteur du Cameroun (CPC), the Institut Pasteur will support the creation of a 4-year Research Group (G4) with a focus on entomology in this institute.
-
Document de presse | 2022.06.20
How to improve the care of childhood encephalitis in South-East Asia
Encephalitis is an acute inflammation of the brain tissue that affects children and adults, especially in South-East Asia. Researchers and physicians involved in the "South-East Asia encephalitis" (SEAe) project, coordinated by the Institut Pasteur in collaboration with the Pasteur Network, have demonstrated the importance of prevention as well as rapid and appropriate diagnosis and treatment of...
-
Article | 2022.06.20
4-year Research Group - Process
WHO CAN APPLY FOR A G4 PI POSITION?The G4 applicant should ideally be an early to mid-career post-doctoral scientist, wishing to establish a research group as an independent researcher. The proposed research project(s) should be innovative and timely yet realistic within the 4-year timeframe of the award. He/she should be able to conduct his/her research in an independent manner, initiate...
-
News | 2022.03.22
Shigella: GMP process for a vaccine candidate from the Institut Pasteur
Intravacc announces the publication of a GMP (Good Manufacturing Practices) process for a semi-synthetic Shigella glycoconjugate vaccine candidate developed at the Institut Pasteur (Paris).Intravacc, a world leader in translational research and development of preventive and therapeutic vaccines, announced the publication of a GMP (Good Manufacturing Practices) manufacturing and formulation...
-
Portrait | 2022.06.24
Sandrine Etienne-Manneville: a strong-minded woman tackling brain cancer head on
It's a day of strikes in Paris and the French capital is virtually paralyzed, but it will take more than that to stop Sandrine Etienne-Manneville from arriving on time to explain her scientific research.She's an old hand at this kind of thing and is enthusiastic as she presents the research she leads with her team in the Cell Polarity, Migration and Cancer Unit.Learning from others and teaching...
-
News | 2022.07.01
Monitoring and early warning: Pasteur Center in Cameroon plays an active role in the response to SARS-CoV-2 virus
As a first-line laboratory in the event of a health emergency, the Pasteur Center in Cameroon was naturally designated as a COVID-19 reference laboratory by the Cameroon health authorities in 2020. How did the Pasteur Center in Cameroon organize its response to this emerging novel virus at national level throughout the epidemic, and how is it monitoring the virus today?At the beginning of the...
-
News | 2022.06.27
The Institut Pasteur and the Institut Curie sign a new strategic agreement that holds great potential for French research
The Institut Pasteur and the Institut Curie have embarked on a new collaborative research strategy. A framework agreement was signed on June 22, 2022 between Professor Sir Stewart Cole, President of the Institut Pasteur, and Professor Thierry Philip, Chairman of the Institut Curie's Executive Board. The aim is to push the boundaries of knowledge in cancer cell biology, immunology and human...
